Navigation Links
AMDL Inc. Announces Second Quarter 2008 Results; Company Posts $5.8 Million in Sales With a Revenue Increase of 140%
Date:8/15/2008

TUSTIN, Calif., Aug. 15 /PRNewswire-FirstCall/ -- (http://www.amdl.com) AMDL Inc. (Amex: ADL), a leading vertically integrated bio-pharmaceutical company with major operations in China and the US, today reported today unaudited results and the filing of its Quarterly Report on Form 10-Q with the Securities and Exchange Commission ("SEC") for the quarter ended June 30, 2008. The Company reported gross revenues of $5.8 million -- an increase of 140% compared with $2.4 million in sales reported for the second quarter of 2007.

Gross profits for the second quarter ended June 30, 2008 increased 152% to $2.9 million compared to $1.1 million for the same period in 2007. The Company's consolidated net losses for the second quarter ended June 30, 2008 were $429,567 or ($0.03) per share compared to a consolidated net loss of $2,264,305 or ($0.17) per share for the same period in 2007. Comprehensive gains after foreign currency translation were $94,448 or $0.006 per share for the second quarter ended June 30, 2008 compared to a loss of $1.9 million.

The lower than expected results for the second quarter of 2008 were in part due delayed revenue recognition from unshipped product for the Company's Domperidone and Goodnak products, higher than expected SG&A expenses, and lost revenues of approximately $110,000 from product donations the Company provided in support of the Sichuan Earthquake disaster relief efforts. Revenue loss as a result of the unshipped Domperidone and Goodnak were the result of interrupted distributor sales cycles also from the earthquake disaster. AMDL is working with its distributor network to accelerate the sales cycles for these products and expects to fully recoup lost
'/>"/>

SOURCE AMDL
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. CV Therapeutics Announces Ranexa(R) Named Finalist for Prix Galien USA 2008 Award
2. Arno Therapeutics Announces Appointment of Brian Lenz, CPA as Chief Financial Officer
3. Fufeng Announces 2008 Interim Results With Strong Sign of Recovery
4. Advanced Life Sciences Announces Second Quarter 2008 Financial Results
5. Ondine Biopharma Announces Second Quarter 2008 Financial Results
6. Indevus Pharmaceuticals Announces Issuance of U.S. Patent for SANCTURA XR(TM)
7. Yongye Biotechnology International Announces Conference Call to Discuss Second Quarter 2008 Results
8. BioMS Medical announces positive interim analysis on phase III trial of dirucotide (MBP8298) for multiple sclerosis
9. Shire Announces Holding of 81% in Jerini AG and Publication of Offer Document
10. POET Announces That Cellulosic Ethanol Pilot Facility Will Be Operational This Year
11. China Medicine Announces Strong Second Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... and SAN JOSE, California , January 15, ... developing antibody-drug conjugates for cancer, today announced the appointment of ... Dr Reynolds has over 20 years, development experience gained in ... Seattle Genetics. "I am delighted to welcome Tom ...
(Date:1/15/2014)... Two champions of science, technology, engineering, and ... annual competition for middle and high school students designed ... study. The competition presents students with real-world problems experienced ... Mathematics, and Sciences is a program administered by ...
(Date:1/15/2014)... (PRWEB) January 15, 2014 AudioNotch is ... new therapy for the treatment of tinnitus. Patients listen ... frequency, and over a period of weeks to months, their ... Therapy in two forms: Notched Music and Notched White Noise. ...
(Date:1/14/2014)... Jan. 14, 2014  3D Communications, a leading provider of strategic communications ... and media events in the United States ... Virginia Cox , JD, is returning to the firm,s ... re-joins 3D after more than two years of service as ...
Breaking Biology Technology:Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5Former FDA Associate Commissioner Returns To 3D Communications 2
... BioMarin,Pharmaceutical Inc. (Nasdaq and SWX: BMRN) today ... will host a,conference call and webcast on Tuesday, ... discuss first quarter 2008 financial results., ... International Dial-in Number: 617.597.5308 Participant Code: ...
... Amsterdam,Molecular Therapeutics (Euronext: AMT), a leader in the ... of the newly created Next Biotech Index of,NYSE Euronext. ... company,for this index," said Ronald Lorijn, CEO of AMT. ... and will help investors to track,the performance of our ...
... and Patient Report,Transfer Across Disparate PACS and Maintains Hospital Group,s ... ... RIS Crashes, SEATTLE, April 8, 2008 Compressus, ... of an integrated digital imaging and data management,solution at E-Rad ...
Cached Biology Technology:BioMarin to Host First Quarter 2008 Financial Results Conference Call and Webcast on Tuesday, April 29 at 5:00 p.m. ET (23:00 CET) 2Amsterdam Molecular Therapeutics Part of Next Biotech Index 2Compressus Completes Interoperability Implementation for E-Rad Solutions Teleradiology Customers 2Compressus Completes Interoperability Implementation for E-Rad Solutions Teleradiology Customers 3
(Date:4/17/2014)... our ideas about domestication derive from Charles Darwin, ... British animal-breeding practices during the 19th century, a ... , It is from Darwin that we ... captive animals from wild species and total human ... animal management in this industrial setting has been ...
(Date:4/16/2014)... University researchers have identified a new syndrome called "osteosarcopenic ... muscle mass with obesity. , "It used to be ... your bones would be because the bones were supporting ... of Nutrition at Florida State. "But, that,s only true ...
(Date:4/16/2014)... Professor Nicolas Doucet of the Centre INRSInstitut Armand-Frappier has just ... (NIH) in the amount of nearly US$600,000. The 5-year grant ... proteins called RNases and to explore their biomedical potential in ... asthma. , "Receiving a grant at this level ...
Breaking Biology News(10 mins):The story of animal domestication retold 2The story of animal domestication retold 3The story of animal domestication retold 4Researchers: Obesity can amplify bone and muscle loss 2High-level NIH grant goes to professor Nicolas Doucet of INRS 2
... have so far been starch and cane sugar. In ... University study was to use only lignocellulose, otherwise known ... production. Another new breakthrough in the ... biotechnology. Finland,s advanced forest industry provides particularly good opportunities ...
... In an example of life imitating art, biologists ... living neon sign composed of millions of bacterial cells ... Their achievement, detailed in this week,s advance online issue ... fluorescent protein to the biological clocks of the bacteria, ...
... that could revolutionize biomedical research, scientists have discovered a way ... from an individual cancer patient alive in the laboratory ... in the lab after dividing only a few times, and ... body. This new technique, described today online in the ...
Cached Biology News:Chemicals and biofuel from wood biomass 2Researchers create living 'neon signs' composed of millions of glowing bacteria 2Researchers create living 'neon signs' composed of millions of glowing bacteria 3Georgetown researchers lead discovery expected to significantly change biomedical research 2
... Proliferator-Activated Receptor-gamma (PPAR) is a member ... ligand-activated transcription factors that heterodimerize with ... involved in the regulation of glucose ... (TZD) class of anti-diabetic agents called ...
... Urine protein analysis can be used for the ... diagnose and/or monitor renal and other diseases. Due ... non-invasively in large amounts, it provides an attractive ... of disease biomarkers. The ProteoSpin Urine Protein ...
... cellular imaging and analysis system is an ... for rapid acquisition and analysis of fluorescence ... ImageXpress is fast. Scanning an entire 384-well ... pixels), with two fluorescence images per well, ...
... The Vibratome Company has joined forces with ... the Vibratome 800 Tissue Chopper. This tissue ... sections of tissue for metabolic experiments and ... irregular specimens available at biopsy or from ...
Biology Products: